TrialEuropean journal of nuclear medicine and molecular imaging2022

Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer's disease: additional results from the AMBAR study.

Gemma Cuberas-Borrós et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.